Highlights and Hope for the Future of GBM Research
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
What started as a small golf outing to remember a beloved friend lost to brain cancer has blossomed into 25 years of a shining legacy and more than $660,000 for crucial brain tumor research.
You probably already know that GBM is a vicious, deadly disease. The question we all have is, what are we going to do about it? As we approach the fourth annual GBM Awareness Day on July 20, 2022, we’re asking you to get involved.
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
Go behind the scenes of the nation’s largest brain tumor conference and hear why the co-chairs say you don’t want to miss this year’s event, Sept. 9-10!
Always free for patients & caregivers
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
800+ children & adults are diagnosed with a brain tumor every single day.